Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Oncology Research 2020

About Oncology and Hematology

Oncology Research 2020 takes a great privilege to welcome you all to the city of Rome situated in Italy for the Conference on Oncology and Hematology, to be held in September 24-25, 2020 in Rome, ItalyOncology Research 2020 is organized by Conference Series LLC Ltd, providing an international platform for the exchange of information in a wide arena of branches of Oncology science.

The Theme of the Conference is Advancements and Emerging Concepts in Oncology and Hematology Researchwhich enables participants to develop their insight into their research field while expanding their perspectives, providing benefits to highly eminent professionals and young researchers.

Oncology Research 2020 benchmark Oncologist, Professors, Scientists, Researchers and Academicians over the globe and incorporates Sessions. Workshops, Symposia ,Video and Poster Presentations gives a closer view to the advancements in the Oncology field and  undergoing changes in its scope, methods, instrumentations and technology which is driven by its increased awareness to the quality health care in many developing countries and advanced biotechnological availability in developed world. It also includes increased application of computer technology in diagnostic science, molecular methods, and clinical measurements, which in turn will affect clinical decisions making with increased accuracy.

We likely entrust you to give us this opportunity to appreciate this event by your appealing views, structures and social legacy on the world's most excellent antiquated city Rome Italy.

Why you should attend Oncology Research 2020??

International conferences are great opportunities not only for researchers and scientists, but also for experts, policy makers, stakeholders and students. Here are six reasons for you to attend International conferences in your field. There is an abundance of academic conferences today as compared to the past. This brings us to a simple question, “Why should one attend an academic conference?” Below are reasons why people say they attend our conferences.

At a conference, innovative ideas are thrown about and new information is exchanged among experts. Its purpose could be one of the following: An academic conference is a gathering of scientists or academicians, where research findings are presented or a workshop is conducted.

Attending a seminar has numerous benefits, including improving communication skills, gaining expert knowledge, networking with others and renewing motivation and confidence.

Learning: Attending conferences, especially the international ones, gives you the chance to listen to different points of view and learn new ideas and trends in your field. They also provide you with new techniques, new types of equipment, data that is yet to be published, and investigators that you may not have heard of. Conferences are priceless chances to sharpen your saw by learning new skills in a different environment.

Discussion: Attending conferences allows you to learn new information and tactics from hearing others’ presentations, you also can converse with other researchers from different universities and even countries you may have only heard or read about.

Presentation: Presenting your research in a conference helps you in different ways. It presents your work to the scientific circles and helps to improve your work by getting feedback from the experts and influencers in your field. Presenting a paper is one of the main objectives of an academic conference participant. The presenter will have the chance to present a paper in front of colleagues of the same or similar fields of study and will be able to receive positive feedback and constructive criticism about their research. The exchange of ideas on fields of interests seeds the links for future collaborations across the world. There are many who were once GAI conference participant’s now developing research projects and writing papers together.

Visiting a new place:  Attending conferences allows you to discover a new place or city where the conference is being held and learn about its people and culture. Many conferences support their attendees with a list of great places they can visit in the conference’ city or country. You can also extend your participation in the conference to a well-deserved holiday in that country and have memorable days.

Networking for future collaborations: International Conferences are great opportunities to connect with attendees from different perspectives and views, learn from them, make new relationships, and strengthen existing ones. Conferences pave the way for scientific cooperation by meeting and connecting with researchers from different countries. They also help in cooperating collective research projects such as edited books, special issues in peer-reviewed journals or funding applications. In addition, Conferences allow Experts, Stakeholders and Policymakers to communicate with researchers with innovative approaches and benefit from these relations in their businesses. Attending an academic conference is an opportunity to build networks with other academics and experts in the same or similar field of studies all around the world and to share thoughts on recent advances and technological breakthroughs. It is an opportunity to expand the knowledge that one has and upgrade performance in accomplishing institutional objectives. Conferences bring together people who share a common discipline from different parts of the world, bringing different forms of ideas which build into something greater.  As you step up and attend conferences you build a network of people who can raise your caliber of work to greater heights as you achieve shared objectives.

Academic Reputation: Attending important international conferences will make you a known figure in academic circles, not to mention the benefits for your resume as it will create an impression that you are an active member of the academic community.

Travelling: An academic conference is a great way to have a “break” from your academic responsibilities at the university and discover different cities of the world. Be assured that you’ll feel relaxed and refreshed when you return to your institution after the conference.

Added Research Value: For students and researchers, academic conferences help to make research on a particular subject easier. They provide access to various research activities related to a particular subject with current findings and developments anticipated from them.

Publication: Another common reason for attending a conference is no doubt publication. Conference proceedings are always a good way to have your research published and indexed. You’ll also have the opportunity to publish your research in one of the journals.

Socialization and the culture factor: Meeting new people with different cultures and dispositions enlightens your way of thinking in your field of study. You will witness some of the many different aspects and solutions which exist on the same issues. You’ll also have the chance to socialize with your colleagues at coffee breaks, lunches and social activities. Imagine a conference without socializing or learning more about other people’s cultural tradition? This cannot be summed up adequately as people from different parts of the world who have uniqueness in their ways of living which you are often surprised to learn from.

Find out what’s new: It is vital to find out what’s new in your field of study to survive in an academic discipline. Academic conferences will keep you updated on new findings that have taken place. This is in fact one of the major reasons why one should attend an academic conference.

The focus and energy of Like-Minded Individuals: When one attends an academic conference he or she is sure to meet people of his or her same stature, mindset and goals. This is a motivational factor as one aspires to overcome fears and achieve one’s dreams.

Conclusion:

In today’s fast changing world, attending a conference has become a “must” to survive in an academic discipline. Many academics have become aware of this fact as the number of conferences and participants increase dramatically. We look forward to collaborating with you at Oncology Research 2020.

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Hematology

Who Should Attend Oncology Reasearch 2020??

Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Industry professionals, Diagnostic laboratory professionals, Academic scientists, Postgraduate students, Postdoctoral fellows, and Trainees can attend

All individuals engaged in cancer care operations should attend the Oncology and Hematology”, including:

Hospital presidents/CEOs/COOs/VPs/trustees

Hospital c-suite executives (operations, development, finance)

Medical directors

Oncology specialists (medical, radiation, and surgical)

Oncology program and practice administrators, managers, and service line executives

Healthcare consultants, vendors, and suppliers

Pharmaceutical and biotechnology manufacturers

Cancer program marketing and public relations professionals

How to find a virtuous conference??

Before you sign up, think about what you hope to gain from attending. Look for a conference that matches your goals for fellowship, medical knowledge, and/or new skills. And you may be surprised at how many opportunities arise.

Conference Series, which organizes 3000+ Global events, 1200+ Symposiums and 1200+Workshops every year is delighted to welcome all the enthusiastic participants across the world to its prestigious Conference on “Oncology and Hematology” which is going to be held September 24-25, 2020 in Rome, Italy. Oncology Reasearch 2020 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.

Tracks/Sessions

Conference Series LLC LTD invites all the participants across the globe to attend the “Oncology Research 2020 Conference” scheduled during September 24-25, 2020 in Rome, Italy.

As the theme of the conference emphasizes ‘Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers’, the Conference is an outstanding international forum to present and discuss progress in exploration, expansion, ideals, and applications of the topics related to the Oncology and Hematology.

In addition to the multidisciplinary talks, Keynote sessions, and lectures relevant to Oncology and Hematology research, the Oncology Research 2020 is a complete 2-day event with panel discussions.

Oncology Research 2020 has been designed with many interesting and informative scientific sessions; it includes all possible aspects of oncology research.

The conference is CME CPD Accredited.

Track 1. Biomarkers in Hematology and Oncology

A cancer biomarker indicates to a substance or process that symbolizes the presence of cancer in the body. A biomarker might be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be preferred for cancer diagnosis, prognosis, and epidemiology. A cancer biomarker refers to a substance that indicates the presence of cancer in the body. A biomarker may be a molecule produced by a tumor or a specific response of the body to the presence of cancer. Epigenetic, proteomic, genetic, glycomic and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology.

 A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer, The most vital use of biomarkers today is to diagnose which therapies a patient’s cancer may or may not respond to

Track 2. Hematology & Oncology Nursing

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist Hematology & Oncology Nursing:, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Often abbreviated to Heme/Onc Nurses are those individuals who work with patient populations undergoing both solid and bloodborne cancer diagnoses, treatment and remission.Management & Palliative Care

Track 3. Cancer: Lifestyle and Nutrition: Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet, body weight and physical activity —especially being overweight or obese—are leading risk factors for obtaining certain types of cancer. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to confront cancer may be helped by succeeding a healthy diet, staying physically active, and escaping excess body fat. Cancer and cancer treatments can also alter your body's ability to tolerate certain foods and use nutrients.

Track 4. Cancer Immunology & Immunotherapy 

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts. The immune response, including the detection of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibod therapieys) and tumor marker-based diagnostic tests.

Track 5. Hematology and Pharma Industry:

The worldwide market of the hematological medications in top point as it is frequently anticipated to be enhanced over the couple of decades. As per the worldwide market expert the haematology medicate and demonstrative market is relied upon to develop at the rate of 7.5% from 2015-2020.

Some of the top pharmacy industries producing Biological Drugs and Generic Drugs incorporate. Takeda oncology, Bristol-Mayers Squibb, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen biotech, Pfizer, Astellas, Bayer, Otsuka, Sanofi, Eisai, AbbVie, Merck KGaA, Pharmacyclics and Incyte.

Track 6. Cancer Prevention

Cancer Prevention is an achievement hauls towards lower possibility of getting disease. Cancer prevention is the practice of taking active measures to decrease the incidence of cancer and mortality. The practice of prevention is dependent upon both individual efforts to improve lifestyle and seek preventative screening and socioeconomic or public policy related to cancer prevention. Greater than a reported 75% of cancer deaths could be prevented by avoiding risk factors including: tobaccooverweight / obesity, an insufficient diet, physical inactivityalcoholsexually transmitted infections, and air pollution.   Malignancy can be taken care of by numerous medications like chemotherapy, radiation treatment, hormonal treatment, target treatment, and palliative consideration.

Track 7. Hormonal Therapy

Hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also be referred to as hormonal therapy or antihormone therapy. Androgen replacement therapy (ART), and transgender hormone therapy. In women, the body of the women is comprised of ovaries. Estrogen creates hormone receptor that prompts the positive bosom malignancy development. Subsequently, gathering the measure of estrogen can abbreviate the danger of an early life-arrange. In few cases, the medical procedure will goes about as a noteworthy job, for example, the ovaries just as the fallopian tubes reallocated by the careful technique so as to treat the hormone-receptor-positive bosom malignant growth. It is important to realize that hormonal treatment isn't hormone substitution treatment (HRT).

Track 8. Key Role of Pathology in Cancer

Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey.. Pathologists are at the heart of cancer prevention through screening, diagnosis, monitoring and treatment. Pathology is the service that handles the blood samples and the cells and tissues removed from suspicious ‘lumps and bumps’. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care.

Track 9. Cancer & Stem Cell Therapy

Cancer stem cells (CSCs) are cancer cells that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Existing cancer treatments have mostly been developed based on animal models, where therapies able to promote tumor shrinkage were deemed effective. 

Track 10. Cancer Nanotechnology

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas. Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterials and nanotechnology approaches to the diagnosis and treatment of cancer.

Track 11. Cancer Chemotherapy

Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgerychemotherapyradiation therapyhormonal therapytargeted therapy and synthetic lethality. Cancer genome sequencing helps in determining which cancer the patient exactly has for determining the best therapy for the cancer. A number of experimental cancer treatments are also under development. Under current estimates, two in five people will have cancer at some point in their lifetime

Track 12. Neonatal and Pediatric Oncology

Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are, NeuroblastomaRetinoblastomaWilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment. 

Track 13. Ovarian Cancer 

Ovarian Cancer is a type of cancer which occurs in one or two of the ovaries. This type of cancer often goes undetected until it is spread to pelvis and uterus at this stage it is much difficult to treat the cancer. Risk factors often include age, family history of cancer, inherited gene mutations, estrogen replacement therapy, age when mensuration started and ended. Ovarian cancer often goes undetected until it has spread within the pelvis and stomach. At this late stage, ovarian cancer is more difficult to treat and can be fatal. Ovarian cancer often has no symptoms in the early stages. Later stages are associated with symptoms, but they can be non-specific, such as loss of appetite and weight loss. Surgery and chemotherapy are generally used to treat ovarian cancer.

Track 14. Oral Oncology

Oral disease is otherwise called mouth tumor. The oral growth may happen at any place in the mouth, on the surface of the tongue, on the lips, inside the cheek, in the gums, in the sense of taste of the mouth, in the salivary organs. Manifestations of oral disease incorporates; fixes on the coating of the mouth or tongue, mouth ulcers or wounds that don't recuperate, free teeth with obvious reason, jaw torment, excruciating tongue, change in voice, ear torment, sore throat and so forth and medicines for Oral growth are surgery, radiation treatment, chemotherapy.

Track 15. Gynecology, Infectious Diseases and Oncology

Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework. Ovarian malignancy, uterine disease, vaginal growth, cervical tumor, and vulvar disease are each of the pieces of gynecologic oncology.

Track 16. Hormone receptor positive breast tumor

A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive tumors (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

Track 17. Hematological Oncology

The finding of treatment and counteractive action of blood illnesses (hematology) and malignancy (oncology) and investigation in them. Hematology-oncology incorporates such sicknesses as iron lack paleness, hemophiliasickle cell illness, the thalassemias, leukemias and lymphomas, and in addition tumors of different organs.

Track 18. Blood Transfusion 

Blood transfusion is a process in which donated blood/blood products are transferred into one’s circulation intravenously. This is a potentially lifesaving procedure used for various medical conditions to replace the lost components of blood due to surgery or injury. However, minor to severe problems do occur occasionally. Most common complications include allergic reactions, blood-borne infections, fever, acute immune hemolytic reaction. 

Track 19. Blood Transplantation, Thrombosis and Hemostasis 

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoietic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large need let that reaches the center of the bone. Acute myeloid leukemia is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.

 

Market Analysis

To Collaborate Scientific Professionals around the World

Conference Date

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by